CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 4 Grant or award Director acquired 8,333 shares (grant or award)
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, GM Gene Therapy acquired 31,500 shares (grant or award)
- 4 Grant or award Chief Legal Officer and Sec. acquired 43,500 shares (grant or award)
- 4 Grant or award Interim CEO acquired 90,000 shares (grant or award)
- 4 Grant or award EVP, GM Cell Therapy acquired 50,825 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, GM Gene Therapy sold 27,894 shares at $3.12 ($87,029)
- 4 Open-market sale SVP, Treasurer & CAO sold 18,020 shares at $3.09 ($55,682)
- 4 Open-market sale General Counsel and Secretary sold 26,500 shares at $3.12 ($82,680)
- 4 Open-market sale EVP, GM Cell Therapy sold 21,620 shares at $2.72 ($58,806)
- 4 Open-market sale President and CEO sold 105,693 shares at $2.71 ($286,428)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 6 of 24 · 465 filings